Skip to content

Clinical trials

Active, not recruiting Coronary Artery Disease trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Artery Disease Status: Active, not recruiting Country / region: China Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20174
20184
20191
20203
20212
20224
20232
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting25

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Nanjing First Hospital, Nanjing Medical University4
Second Affiliated Hospital, Zhejiang University, School of Medicine4
Changhai Hospital3
Biotyx Medical (Shenzhen) Co., Ltd.2
Medtronic Vascular2
Novartis Pharmaceuticals2
Beijing Anzhen Hospital1
China National Center for Cardiovascular Diseases1
Chinese Academy of Medical Sciences, Fuwai Hospital1
First Affiliated Hospital of Guangxi Medical University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Artery Disease25
Cardiovascular Diseases3
Myocardial Infarction3
Arteriosclerosis2
Coronary Stenosis2
Myocardial Ischemia2
Atherosclerosis1
Calcinosis1
Dyslipidemias1
Hypercholesterolemia1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.